Meng Du

892 total citations
26 papers, 680 citations indexed

About

Meng Du is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Meng Du has authored 26 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Meng Du's work include PARP inhibition in cancer therapy (6 papers), Adipose Tissue and Metabolism (4 papers) and Signaling Pathways in Disease (4 papers). Meng Du is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), Adipose Tissue and Metabolism (4 papers) and Signaling Pathways in Disease (4 papers). Meng Du collaborates with scholars based in China, United States and Italy. Meng Du's co-authors include Kai Huang, Fengxiao Zhang, Dan Huang, Kun Huang, Xiangrao Li, Xiaoxiang Mao, Xi Luo, Xin Tan, Yan Wang and Dandan Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Meng Du

24 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meng Du China	12	375	216	142	139	124	26	680
Xiangrao Li China	10	310 0.8×	242 1.1×	109 0.8×	88 0.6×	102 0.8×	12	558
Jingti Deng China	16	434 1.2×	157 0.7×	103 0.7×	84 0.6×	75 0.6×	31	767
Xi Jiang China	14	366 1.0×	126 0.6×	173 1.2×	91 0.7×	200 1.6×	27	740
Arianna Marino Italy	15	378 1.0×	265 1.2×	231 1.6×	188 1.4×	217 1.8×	16	858
Susmita Chakrabarti United States	16	529 1.4×	149 0.7×	96 0.7×	102 0.7×	68 0.5×	20	891
Xiaodong Peng China	18	410 1.1×	75 0.3×	182 1.3×	98 0.7×	84 0.7×	49	873
Yinghong Zhu China	14	361 1.0×	115 0.5×	60 0.4×	130 0.9×	90 0.7×	34	682
Jiaqing Hao United States	16	508 1.4×	305 1.4×	293 2.1×	148 1.1×	102 0.8×	32	867
Kelly D. McCall United States	16	346 0.9×	99 0.5×	270 1.9×	139 1.0×	89 0.7×	35	780

Countries citing papers authored by Meng Du

Since Specialization

Citations

This map shows the geographic impact of Meng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Du more than expected).

Fields of papers citing papers by Meng Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Du. The network helps show where Meng Du may publish in the future.

Co-authorship network of co-authors of Meng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Du. A scholar is included among the top collaborators of Meng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Du. Meng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Di, et al.. (2025). Transducin-like enhancer of split 3 protects against lipopolysaccharide-induced inflammation through DEAD-box helicase 5–activating transcription factor 1–protein phosphatase 2 regulatory subunit 5A signaling. Journal of Advanced Research. 79. 661–677.

Wang, Yilong, Minglu Liang, Kaiyuan Liu, et al.. (2025). BAP1 Suppresses White Adipose Tissue Browning and Thermogenesis Through Deubiquitinating KDM1B. Diabetes. 74(7). 1153–1167.

Zhong, Yi, et al.. (2025). TRIM56 Promotes White Adipose Tissue Browning to Attenuate Obesity by Degrading TLE3. Advanced Science. 12(13). e2414073–e2414073. 1 indexed citations

Du, Meng, et al.. (2024). Pimpinellin ameliorates macrophage inflammation by promoting RNF146‐mediated PARP1 ubiquitination. Phytotherapy Research. 38(4). 1783–1798. 11 indexed citations

Zhong, Yi, Dandan Huang, Yang Liu, et al.. (2023). LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis. Metabolism. 148. 155609–155609. 6 indexed citations

Du, Meng, Cheng Wang, Bing Liu, et al.. (2022). The role of long noncoding RNA Nron in atherosclerosis development and plaque stability. iScience. 25(3). 103978–103978. 11 indexed citations

Yuan, Lin, Meng Du, Yilong Wang, et al.. (2022). RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovascular Research. 119(1). 183–194. 19 indexed citations

Du, Meng, Liu Yang, Bing Liu, et al.. (2021). Inhibition of NFAT suppresses foam cell formation and the development of diet‐induced atherosclerosis. The FASEB Journal. 35(10). e21951–e21951. 10 indexed citations

Du, Meng, Xiaojing Wang, Yuan Lin, et al.. (2020). Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology. 73(6). 1333–1346. 29 indexed citations

10.

Zhang, Shuo, Fengxiao Zhang, Meng Du, Kun Huang, & Cheng Wang. (2019). Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis. British Journal Of Nutrition. 121(8). 841–848. 11 indexed citations

11.

Du, Meng, Xiaojing Wang, Xiaoxiang Mao, et al.. (2019). Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. Theranostics. 9(16). 4688–4703. 33 indexed citations

12.

Wang, Cheng, Meng Du, Dan Huang, Kun Huang, & Kai Huang. (2019). Inhibition of PARP1 Increases IRF-dependent Gene Transcription in Jurkat Cells. Current Medical Science. 39(3). 356–362. 3 indexed citations

13.

Du, Meng, Yuan Lin, Xin Tan, et al.. (2017). The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature Communications. 8(1). 2049–2049. 213 indexed citations

14.

Huang, Kun, Meng Du, Xin Tan, et al.. (2016). PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. Journal of Hepatology. 66(5). 962–977. 79 indexed citations

15.

Du, Meng, Xiaojing Wang, Xin Tan, et al.. (2016). Nkx2‐5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E–Deficient Mice. Journal of the American Heart Association. 5(12). 9 indexed citations

16.

Du, Meng, Kun Huang, Dan Huang, et al.. (2014). Renalase is a novel target gene of hypoxia-inducible factor-1 in protection against cardiac ischaemia–reperfusion injury. Cardiovascular Research. 105(2). 182–191. 43 indexed citations

17.

Liu, Yang, Kun Huang, Xiangrao Li, et al.. (2013). Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells. PLoS ONE. 8(12). e82872–e82872. 26 indexed citations

18.

Du, Meng, Kun Huang, Lu Gao, et al.. (2013). Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(6). 822–826. 17 indexed citations

19.

Zhang, Fengxiao, Yan Wang, Lin Wang, et al.. (2013). Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription. Journal of Biological Chemistry. 288(16). 11348–11357. 57 indexed citations

20.

Wang, Cheng, Fengxiao Zhang, Lin Wang, et al.. (2013). Poly(ADP-Ribose) Polymerase 1 Promotes Oxidative-Stress-Induced Liver Cell Death via Suppressing Farnesoid X Receptor α. Molecular and Cellular Biology. 33(22). 4492–4503. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact